Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Orange City, FL
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Orange City, FL
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Atlanta, GA
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Suwanee, GA
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Suwanee, GA
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Quincy, MA
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Quincy, MA
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Toms River, NJ
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Brooklyn, NY
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
New Hyde Park, NY
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Hickory, NC
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Hickory, NC
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Raleigh, NC
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Waukesha, WI
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Waukesha, WI
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Lakewood, CA
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Lakewood, CA
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Sarasota, FL
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Charlotte, NC
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Dallas, TX
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Study Site
mi
from
Burgas,
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Study Site
mi
from
Burgas,
Click here to add this to my saved trials
American Indian and Alaska Native Men Who Have Sex With Men HIV & Substance Abuse Research
American Indian and Alaska Native Men Who Have Sex With Men HIV & Substance Abuse Research
Status: Enrolling
Updated:  4/27/2018
Univ of Washington
mi
from
Seattle, WA
American Indian and Alaska Native Men Who Have Sex With Men HIV & Substance Abuse Research
American Indian and Alaska Native Men Who Have Sex With Men HIV & Substance Abuse Research
Status: Enrolling
Updated: 4/27/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Comparison of Psychotherapy Programs to Treat Panic Disorder
Dynamic Treatment vs. CBT for Panic Disorder
Status: Enrolling
Updated:  4/30/2018
Weill Medical College of Cornell University
mi
from
New York, NY
Comparison of Psychotherapy Programs to Treat Panic Disorder
Dynamic Treatment vs. CBT for Panic Disorder
Status: Enrolling
Updated: 4/30/2018
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Comparison of Psychotherapy Programs to Treat Panic Disorder
Dynamic Treatment vs. CBT for Panic Disorder
Status: Enrolling
Updated:  4/30/2018
University of Pennsylvania School of Medicine
mi
from
Philadelphia, PA
Comparison of Psychotherapy Programs to Treat Panic Disorder
Dynamic Treatment vs. CBT for Panic Disorder
Status: Enrolling
Updated: 4/30/2018
University of Pennsylvania School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effects of Inhaled Cannabis on Driving Performance
Effects of Inhaled Cannabis on Driving Performance
Status: Enrolling
Updated:  4/30/2018
National Advanced Driving Simulator
mi
from
Iowa City, IA
Effects of Inhaled Cannabis on Driving Performance
Effects of Inhaled Cannabis on Driving Performance
Status: Enrolling
Updated: 4/30/2018
National Advanced Driving Simulator
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Statewide Trial to Compare Three Training Models for Implementing an Evidence-based Treatment (EBT)
A Statewide Trial to Compare Three Training Models for Implementing an EBT
Status: Enrolling
Updated:  4/30/2018
University of Pittsburgh School of Medicine
mi
from
Pittsburgh, PA
A Statewide Trial to Compare Three Training Models for Implementing an Evidence-based Treatment (EBT)
A Statewide Trial to Compare Three Training Models for Implementing an EBT
Status: Enrolling
Updated: 4/30/2018
University of Pittsburgh School of Medicine
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Open-Label Extension Study of Kuvan for Autism
Kuvan® (Sapropterin) as a Treatment for Autistic Disorder: An Open Label Extension Protocol
Status: Enrolling
Updated:  4/30/2018
The Children's Health Council
mi
from
Palo Alto, CA
Open-Label Extension Study of Kuvan for Autism
Kuvan® (Sapropterin) as a Treatment for Autistic Disorder: An Open Label Extension Protocol
Status: Enrolling
Updated: 4/30/2018
The Children's Health Council
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Delirium in the Emergency Department: Novel Screening
Delirium in the Emergency Department: Novel Screening
Status: Enrolling
Updated:  5/1/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Delirium in the Emergency Department: Novel Screening
Delirium in the Emergency Department: Novel Screening
Status: Enrolling
Updated: 5/1/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Family and Adolescent Motivational Incentives for Leveraging Youth
Family and Adolescent Motivational Incentives for Leveraging Youth
Status: Enrolling
Updated:  5/1/2018
Oregon Research Institute Center for Family and Adolescent Research
mi
from
Albuquerque, NM
Family and Adolescent Motivational Incentives for Leveraging Youth
Family and Adolescent Motivational Incentives for Leveraging Youth
Status: Enrolling
Updated: 5/1/2018
Oregon Research Institute Center for Family and Adolescent Research
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Status: Enrolling
Updated:  5/1/2018
Oregon Research Institute
mi
from
Eugene, OR
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Status: Enrolling
Updated: 5/1/2018
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Status: Enrolling
Updated:  5/1/2018
Seattle Children'S Research Institute
mi
from
Seattle, WA
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Status: Enrolling
Updated: 5/1/2018
Seattle Children'S Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Improving Negative Symptoms of Psychosis In Real-world Environments
Improving Negative Symptoms of Psychosis In Real-world Environments
Status: Enrolling
Updated:  5/1/2018
UCSD
mi
from
La Jolla, CA
Improving Negative Symptoms of Psychosis In Real-world Environments
Improving Negative Symptoms of Psychosis In Real-world Environments
Status: Enrolling
Updated: 5/1/2018
UCSD
mi
from
La Jolla, CA
Click here to add this to my saved trials
Hybrid Collaborative Care Randomized Program Evaluation
Hybrid Controlled Trial to Implement Collaborative Care in General Mental Health
Status: Enrolling
Updated:  5/1/2018
VA Boston Healthcare System
mi
from
Boston, MA
Hybrid Collaborative Care Randomized Program Evaluation
Hybrid Controlled Trial to Implement Collaborative Care in General Mental Health
Status: Enrolling
Updated: 5/1/2018
VA Boston Healthcare System
mi
from
Boston, MA
Click here to add this to my saved trials
Screening Protocol for Adults With ADHD
A Screening Protocol for Adults With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  5/2/2018
Massachusetts General Hospital
mi
from
Boston, MA
Screening Protocol for Adults With ADHD
A Screening Protocol for Adults With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 5/2/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Novel Treatment of Emotional Dysfunction in Post Traumatic Stress Disorder (PTSD)
Novel Treatment of Emotional Dysfunction in PTSD
Status: Enrolling
Updated:  5/2/2018
The University of Texas at Dallas
mi
from
Dallas, TX
Novel Treatment of Emotional Dysfunction in Post Traumatic Stress Disorder (PTSD)
Novel Treatment of Emotional Dysfunction in PTSD
Status: Enrolling
Updated: 5/2/2018
The University of Texas at Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Pilot Study of a Brief Intervention for Medically Hospitalized Suicide Attempt Survivors
Pilot Study of a Brief Intervention for Medically Hospitalized Suicide Attempt Survivors
Status: Enrolling
Updated:  5/2/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Pilot Study of a Brief Intervention for Medically Hospitalized Suicide Attempt Survivors
Pilot Study of a Brief Intervention for Medically Hospitalized Suicide Attempt Survivors
Status: Enrolling
Updated: 5/2/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials